Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This FOXO4p53 interaction is essential for maintaining the viability of senescent cells
However, retatrutide has not received approval from the MHRA or the EMA and remains an investigational agent undergoing Phase 3 trials
Handling and Stability Risks Improper handling exposure to light, heat, repeated freeze-thaw cycles, or strongly alkaline conditions can degrade the peptide or disrupt copper coordination, producing experimental variability that is sometimes mistaken for biological inconsistency
Mechanism and magnitude
Ilic S, Brcic I, Mester M, Filipovic M, Sever M, Klicek R, et al
Please let me know your thoughts
US$ 22.14
US$ 27.60
US$ 21.45
US$ 21.75
US$ 25.04
US$ 29.50
US$ 24.48
US$ 25.85
US$ 27.01
